COVID-19 Updates
Being immunocompromised mandates that those living with CLL and SLL stay well- informed in order to plan ahead. Performing individualized risk-assessments based on the most recent data available help to keep us informed so we can know how to advocate for receiving the best possible care should COVID-19 infection occur.
As needed, CLL Society posts updates and provides background information on new research in an effort to keep our community informed. The information presented will remain focused on reliable scientific sources of information and avoid most of the news that is not directly coming from reliable medical experts or government and world health agencies.
FEATURE
New COVID Vaccine Boosts Cellular Response in CLL Patients
CLL patients often have suboptimal COVID-19 vaccine responses and worse outcomes. GEO-CM04S1, a new type of vaccine, results in stronger T cell immunity. This may result in better protection against COVID-19.